Cargando…
Discovery and Validation of Hypermethylated Markers for Colorectal Cancer
Colorectal carcinoma (CRC) is one of the most prevalent malignant tumors worldwide. Screening and early diagnosis are critical for the clinical management of this disease. DNA methylation changes have been regarded as promising biomarkers for CRC diagnosis. Here, we map DNA methylation profiling on...
Autores principales: | Wei, Jiufeng, Li, Guodong, Dang, Shuwei, Zhou, Yuhui, Zeng, Kai, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963574/ https://www.ncbi.nlm.nih.gov/pubmed/27493446 http://dx.doi.org/10.1155/2016/2192853 |
Ejemplares similares
-
Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer
por: Wei, Jiufeng, et al.
Publicado: (2016) -
Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer
por: Lin, Ruo-Kai, et al.
Publicado: (2017) -
No SMAD4 hypermethylation in colorectal cancer
por: Roth, S, et al.
Publicado: (2000) -
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020) -
Detection of Hypermethylated Spastic Paraplegia-20 in Stool Samples of Patients with Colorectal Cancer
por: Zhang, Hao, et al.
Publicado: (2013)